Briquilimab-Based Nonmyeloablative Conditioning in Older Adults with High-Risk AML/MDS – Resonance

The ALRCaN Global webinar, “Nonmyeloablative Conditioning Combined with the Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDS,” is scheduled for Friday, September 11, 2026, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT).
Presented by Lori Muffly and organized by the Acute Leukemia Research and Care Network (ALRCaN), the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard, Stacy Cooper, Archie Bleyer, Dan Douer, and the Resonance Team.